未登录

S

Shuhua Tan

China Pharmaceutical University

H指数:13

被引数:474

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Different Adjuvants on the Immunogenicity of a Recombinant Herpes Zoster Vaccine in Mice, Rats and Non-Human Primates

不同佐剂对重组带状疱疹疫苗在小鼠、大鼠和非人灵长类动物免疫原性的影响

Vaccines 2025, Vol. 13, Page 1124

IF3.4

2025-10-310

OAAI

Restoration of miR-299-3p promotes efferocytosis and ameliorates atherosclerosis via repressing CD47 in mice

miR-299-3p的恢复通过抑制CD47促进小鼠的胞吞作用并改善动脉粥样硬化

IF4.2

2024-08-080

OA

Restoration of miR-299-3p promotes macrophage phagocytosis and suppresses malignant phenotypes in breast cancer carcinogenesis via dual-targeting CD47 and ABCE1

miR-299-3p的恢复通过双重靶向CD47和ABCE1促进巨噬细胞吞噬并抑制乳腺癌癌变中的恶性表型

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-03-010

PRE

Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2024-03-011

OAAI

A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice

IF4.2

2024-01-040

PRE

A bifunctional anti-PCSK9 scFv/Exendin-4 fusion protein exhibits enhanced lipid-lowering effects via targeting multiple signaling pathways in HFD-fed mice

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-12-010

PRE

Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia

IF3.9

2021-11-273

OAAI

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy

IF10.8

2021-03-0116

OAAI

Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes

ATHEROSCLEROSIS

IF5.7

2020-03-0123

PREAI

Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE-/- Mice

IF4.6

2019-11-155

OAAI

Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE-/- mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway

IF4.2

2019-01-0242

OAAI

Combination of novel DR5 targeting agonistic scFv antibody TR2-3 with cisplatin shows enhanced synergistic antitumor activity in vitro and in vivo

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2018-02-015

PREAI

LOCALISATION OF THE GLYCOLYTIC ISOZYME, PYRUVATE KINASE M2 IN THE LUNG OF IDIOPATHIC PULMONARY FIBROSIS

IF7.7

2017-11-150

OAAI

Efficient Production of Native Lunasin with Correct N-terminal Processing by Using the pH-Induced Self-Cleavable Ssp DnaB Mini-intein System in Escherichia coli

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

IF3.3

2014-08-0213

PREAI

Robust preparative-scale extracellular production of hirudin in Escherichia coli and its purification and characterization

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY

IF3.2

2012-10-0111

OA

Mucin biosynthesis:: Molecular cloning and expression of mouse mucus-type core 2 β1,6 N-acetylglucosaminyltransferase

IF3.3

2007-06-2513

OAAI

Mucin biosynthesis - Identification of the cis-regulatory elements of human C2GnT-M gene

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

IF5.3

2007-06-0117

OAAI